185 related articles for article (PubMed ID: 7914428)
1. Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.
Sulkes A; Smyth J; Sessa C; Dirix LY; Vermorken JB; Kaye S; Wanders J; Franklin H; LeBail N; Verweij J
Br J Cancer; 1994 Aug; 70(2):380-3. PubMed ID: 7914428
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.
ten Bokkel Huinink WW; Prove AM; Piccart M; Steward W; Tursz T; Wanders J; Franklin H; Clavel M; Verweij J; Alakl M
Ann Oncol; 1994 Jul; 5(6):527-32. PubMed ID: 7918124
[TBL] [Abstract][Full Text] [Related]
3. Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
Mavroudis D; Kourousis C; Androulakis N; Kalbakis K; Agelaki S; Kakolyris S; Souglakos J; Sarra E; Vardakis N; Hatzidaki D; Sarmonis G; Georgoulias V
Am J Clin Oncol; 2000 Aug; 23(4):341-4. PubMed ID: 10955859
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Catimel G; Verweij J; Mattijssen V; Hanauske A; Piccart M; Wanders J; Franklin H; Le Bail N; Clavel M; Kaye SB
Ann Oncol; 1994 Jul; 5(6):533-7. PubMed ID: 7918125
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group.
Aamdal S; Wolff I; Kaplan S; Paridaens R; Kerger J; Schachter J; Wanders J; Franklin HR; Verweij J
Eur J Cancer; 1994; 30A(8):1061-4. PubMed ID: 7654429
[TBL] [Abstract][Full Text] [Related]
6. [A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
Mai M; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N; Taguchi T; Furue H
Gan To Kagaku Ryoho; 1999 Mar; 26(4):487-96. PubMed ID: 10097745
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC Early Clinical Trials Group.
Bruntsch U; Heinrich B; Kaye SB; de Mulder PH; van Oosterom A; Paridaens R; Vermorken JB; Wanders J; Franklin H; Bayssas M
Eur J Cancer; 1994; 30A(8):1064-7. PubMed ID: 7654430
[TBL] [Abstract][Full Text] [Related]
8. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)].
Taguchi T; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1915-24. PubMed ID: 9797814
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.
Chevallier B; Fumoleau P; Kerbrat P; Dieras V; Roche H; Krakowski I; Azli N; Bayssas M; Lentz MA; Van Glabbeke M
J Clin Oncol; 1995 Feb; 13(2):314-22. PubMed ID: 7844592
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG).
Cerny T; Kaplan S; Pavlidis N; Schöffski P; Epelbaum R; van Meerbeek J; Wanders J; Franklin HR; Kaye S
Br J Cancer; 1994 Aug; 70(2):384-7. PubMed ID: 7914429
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel delivers new management opportunities for gastrointestinal carcinomas.
Rougier P
Anticancer Drugs; 1995 Jul; 6 Suppl 4():25-9. PubMed ID: 8745351
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of docetaxel in advanced soft tissue sarcomas.
Edmonson JH; Ebbert LP; Nascimento AG; Jung SH; McGaw H; Gerstner JB
Am J Clin Oncol; 1996 Dec; 19(6):574-6. PubMed ID: 8931674
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study.
Sternberg CN; ten Bokkel Huinink WW; Smyth JF; Bruntsch V; Dirix LY; Pavlidis NA; Franklin H; Wanders S; Le Bail N; Kaye SB
Br J Cancer; 1994 Aug; 70(2):376-9. PubMed ID: 7914427
[TBL] [Abstract][Full Text] [Related]
14. A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer.
Dieras V; Chevallier B; Kerbrat P; Krakowski I; Roche H; Misset JL; Lentz MA; Azli N; Murawsky M; Riva A; Pouillart P; Fumoleau P
Br J Cancer; 1996 Aug; 74(4):650-6. PubMed ID: 8761385
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.
Einzig AI; Neuberg D; Remick SC; Karp DD; O'Dwyer PJ; Stewart JA; Benson AB
Med Oncol; 1996 Jun; 13(2):87-93. PubMed ID: 9013471
[TBL] [Abstract][Full Text] [Related]
16. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
[TBL] [Abstract][Full Text] [Related]
17. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
Hudis CA; Seidman AD; Crown JP; Balmaceda C; Freilich R; Gilewski TA; Hakes TB; Currie V; Lebwohl DE; Baselga J; Raptis G; Gollub M; Robles M; Bruno R; Norton L
J Clin Oncol; 1996 Jan; 14(1):58-65. PubMed ID: 8558221
[TBL] [Abstract][Full Text] [Related]
18. Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC.
Smyth JF; Smith IE; Sessa C; Schoffski P; Wanders J; Franklin H; Kaye SB
Eur J Cancer; 1994; 30A(8):1058-60. PubMed ID: 7654428
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma.
Clark TB; Kemeny NE; Conti JA; Huang Y; Andre AM; Stockman J
Cancer Invest; 1998; 16(5):314-8. PubMed ID: 9627678
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of docetaxel in advanced non-small cell lung cancer.
Saarinen A; Jekunen A; Halme M; Pyrhönen S; Tamminen K; Boyer R; Roubille N; Mattson K
Anticancer Drugs; 1996 Nov; 7(8):890-2. PubMed ID: 8991195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
